3645 results for «2664»

Filter By

3645 results

Multivessel complications: what can go wrong

21 May 2026 – From EuroPCR 2026

This session highlights complications encountered in multivessel coronary interventions, presenting complex cases such as lost stents, coronary perforations, shaft fractures, early subacute stent thrombosis, and rare triple vessel thrombosis. It emphasizes practical management strategies for these challenging scenarios in contemporary interventional cardiology.

Multivessel complications: what can go wrong

INOCA/ANOCA: view insights from clinical practice

19 May 2026 – From EuroPCR 2026

This session provides in-depth clinical insights into INOCA and ANOCA by exploring innovative invasive assessments of coronary microcirculation and vasoreactivity, with a focus on diabetic populations and sex differences. It reviews distinct IMR-based phenotypes differentiating flow versus pressure-driven microvascular dysfunction, and the role of invasive hemodynamics...

News from drug-eluting therapies in 2026

19 May 2026 – From EuroPCR 2026

This session presents the latest advancements in drug-eluting therapies for 2026, including predictors of target lesion failure after drug-coated balloon treatment, clinical outcomes related to stenting length, and novel insights into sirolimus transfer evidenced by in vivo OCT imaging.

New data on intracoronary imaging-guided interventions

21 May 2026 – From EuroPCR 2026

This session presents new data on intracoronary imaging-guided interventions, comparing outcomes of angiography-derived FFR and IVUS-guided PCI over two years, as well as OCT versus IVUS for intermediate left main stenosis. It further evaluates high-risk non-culprit lesions post-myocardial infarction, the role of coronary lipid burden in...

New data on intracoronary imaging-guided interventions

Radial and distal radial artery access for PCI

19 May 2026 – From EuroPCR 2026

This session provides an in-depth evaluation of radial and distal radial artery access for PCI, including a 20-year trend analysis of clinical outcomes, feasibility studies on distal radial interventions, and comparative real-world experiences. It also features meta-analyses of randomized trials on access approaches and early findings...

All you need to know of DAPT in ACS

21 May 2026 – From EuroPCR 2026

This session provides an in-depth review of dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS), focusing on strategies for safe de-escalation and P2Y12 inhibitor monotherapy to reduce bleeding risk without compromising ischemic protection. It also covers optimizing antithrombotic therapy in patients on oral anticoagulation and...

All you need to know of DAPT in ACS

Treatment for calcified coronary artery disease in the real world

19 May 2026 – From EuroPCR 2026

This session presents real-world experiences and evidence on treating calcified coronary artery disease. It includes meta-analyses comparing rotational atherectomy and balloon angioplasty, long-term outcomes of excimer laser atherectomy, and multicenter registry data on intravascular lithotripsy (IVL), particularly in diabetic and high-risk patients. The session also focuses...

TAVI complications: impact and improvement

20 May 2026 – From EuroPCR 2026

This session examines critical complications associated with TAVI and strategies to mitigate their impact. Topics include carbon-dioxide flushing to reduce brain injury, management of cardiac tamponade, AI-driven customization of TAVI in complex anatomies, and the influence of vascular complications on post-procedural quality of life.

A series of complex real-word challenges STEMI treatment from very different countries

21 May 2026 – From EuroPCR 2026

This session showcases a series of complex STEMI treatment challenges from diverse international settings, highlighting difficult coronary anatomies and complicated procedures. It discusses nuanced clinical scenarios where artery recanalisation does not always equate to reperfusion, and presents stepwise approaches to managing multivessel disease, renal failure, and...

INOCA/ANOCA: technical aspects

20 May 2026 – From EuroPCR 2026

This session covers technical aspects critical to the evaluation and management of ischemia with non-obstructive coronary arteries (INOCA) and angina with non-obstructive coronary arteries (ANOCA). Key topics include the impact of guide catheter shape, injection techniques for thermodilution measurements, advanced perfusion CMR diagnostics, and the physiological...

Bifurcation and heavily calcified lesions

21 May 2026 – From EuroPCR 2026

This session addresses the evaluation and treatment of bifurcation and heavily calcified coronary lesions. It includes case-based discussions on complex left main PCI and the use of drug-coated balloons (DCB) for bifurcation lesions and in-stent restenosis, providing evidence-based approaches to optimize outcomes in these challenging lesion...

FFR and non-hyperaemic pressure ratios

20 May 2026 – From EuroPCR 2026

This session presents contemporary clinical applications of fractional flow reserve (FFR) and non-hyperaemic pressure ratios (NHPR), highlighting real-world impacts of physiology microcatheter-based indices, the interplay between epicardial stenosis and microvascular resistance, post-PCI hyperemia effects on iFR, and machine-learning driven outcome predictions.

Other right-sided and tricuspid valve interventions

20 May 2026 – From EuroPCR 2026

This session focuses on right-sided heart valve interventions, particularly targeting tricuspid valve disease. Topics include clinical outcomes in atrial functional tricuspid regurgitation, management in the context of left-sided valvular disease, treatment approaches for tricuspid valve endocarditis, and advances in transcatheter therapies and device placements.

Complication management during STEMI intervention: Czech Republic - Greece and Iraq present their cases

21 May 2026 – From EuroPCR 2026

This session presents a critical analysis of procedural strategies in primary PCI for STEMI by exploring complex cases from the Czech Republic, Greece, and Iraq. It delves into mechanisms and management of major PCI complications and highlights the role of emerging novel technologies in primary PCI...

Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award

20 May 2026 – From EuroPCR 2026

The Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award session celebrates outstanding contributions to cardiovascular research and innovation. It highlights achievements by emerging investigators, recognizing excellence that advances the field of cardiology and inspires future clinical and scientific endeavors.

Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award

PCR's Got Talent Award, best abstract & best case Awards

22 May 2026 – From EuroPCR 2026

This session celebrates excellence in interventional cardiology through the PCR's Got Talent Award, highlighting the best abstracts and case presentations. It showcases innovative research and exemplary clinical cases that advance the field, fostering professional recognition and knowledge dissemination.

PCR's Got Talent Award, best abstract & best case Awards

Personalised Vascular Care Award - Ceremony

20 May 2026 – From EuroPCR 2026

The Personalised Vascular Care Award Ceremony celebrated outstanding achievements in the advancement of personalized vascular treatment approaches, recognizing leaders who have contributed significantly to improving patient outcomes in vascular care.

Personalised Vascular Care Award - Ceremony

EuroPCR 2026 Closing Ceremony

22 May 2026 – From EuroPCR 2026

The EuroPCR 2026 Closing Ceremony marks the conclusion of this premier cardiology event, celebrating the latest advances and achievements in interventional cardiology. It offers an opportunity to reflect on the educational sessions, network with peers, and recognize outstanding contributions to the field.

EuroPCR 2026 Closing Ceremony

Welcome to EuroPCR 2026

19 May 2026 – From EuroPCR 2026

Welcome to EuroPCR 2026, the premier event for interventional cardiology professionals. This edition offers cutting-edge scientific presentations, live cases, and interactive sessions designed to advance knowledge and clinical practice in cardiovascular interventions.

Welcome to EuroPCR 2026

Insight from recent evidence in coronary artery disease: value of DCB for de novo lesions (SELUTION) and imaging for left main PCI (OPTIMAL)

21 May 2026 – From EuroPCR 2026

This session reviews pivotal recent evidence impacting daily practice in coronary artery disease management. It discusses the role of drug-coated balloons (DCB) for de novo lesions as evaluated in the SELUTION trial and evaluates intracoronary imaging strategies for left main PCI as presented in the OPTIMAL...

Insight from recent evidence in coronary artery disease: value of DCB for de novo lesions (SELUTION) and imaging for left main PCI (OPTIMAL)
Didn’t find what you were looking for?